Cannabis finance news

Vitura Health reports first-half loss as price war continues to hit margins

by Steve Jones February 25, 2026February 25, 2026

Vitura Health has reported a “challenging” first half which saw the business slide into the red […]

Nexalis outlines 2026 plan as IRX shares jump 35%

by Adam Sheldon February 17, 2026February 19, 2026

Cannim liquidator draws up timeframe for potential litigation and court-ordered director examinations

by Steve Jones February 10, 2026February 10, 2026

Tensions run high as creditors vote to wind up Cannim Group

by Steve Jones February 5, 2026February 5, 2026

Cannatrek ‘evolution’ key to merger, says LGP managing director

by Adam Sheldon February 3, 2026February 5, 2026

Financial news in brief: Avecho; InhaleRx; Neurotech; Peak; Zelira; Argent

by Adam Sheldon February 2, 2026June 8, 2026

Elixinol records first underlying operating cash flow positive quarter

by Adam Sheldon February 2, 2026February 3, 2026

Cann Group to review guidance after starting post-NAB era with ‘unexpectedly’ soft revenue

by Steve Jones January 30, 2026February 3, 2026

European growth helps LGP report record quarter of revenue

by Steve Jones January 30, 2026February 3, 2026

Vitura Health CEO let go as board says ‘new leadership was required’

by Steve Jones January 29, 2026January 29, 2026